z-logo
open-access-imgOpen Access
Pancreatic Cancer
Author(s) -
Niccola Funel,
Marco Del Chiaro,
Djuna L. Cahen,
Johanna Laukkarinen
Publication year - 2015
Publication title -
gastroenterology research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 45
eISSN - 1687-630X
pISSN - 1687-6121
DOI - 10.1155/2015/809036
Subject(s) - medicine , pancreatic cancer , traditional medicine , cancer
Pancreatic cancer currently carries with it a poor prognosis. This is, in part, due to the fact that early stage disease is relatively symptom-free. Most cases are therefore diagnosed at later stages. Without active treatment the median survival length is around 3 to 5 months which extends to around 11 to 15 months with proper treatment . Due to the generally late diagnoses, more than 80% of the cancers are not treatable via surgery. Although diagnosis methods are becoming more advanced every year, the American Cancer Society estimates that in the year 2018, 55,440 people will be diagnosed with pancreatic cancer and there will be 44,330 deaths. These statistics make pancreatic cancer the 4th overall cause of cancer related deaths in the U.S.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom